These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 30409518)

  • 41. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gamma-secretase modulation with Abeta42-lowering nonsteroidal anti-inflammatory drugs and derived compounds.
    Czirr E; Weggen S
    Neurodegener Dis; 2006; 3(4-5):298-304. PubMed ID: 17047371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
    Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
    Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alzheimer's disease and Notch signaling.
    Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The amyloid precursor protein C-terminal fragment C100 occurs in monomeric and dimeric stable conformations and binds γ-secretase modulators.
    Botev A; Munter LM; Wenzel R; Richter L; Althoff V; Ismer J; Gerling U; Weise C; Koksch B; Hildebrand PW; Bittl R; Multhaup G
    Biochemistry; 2011 Feb; 50(5):828-35. PubMed ID: 21186781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
    Iwatsubo T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NSAID-derived γ-secretase modulation requires an acidic moiety on the carbazole scaffold.
    Zall A; Kieser D; Höttecke N; Naumann EC; Thomaszewski B; Schneider K; Steinbacher DT; Schubenel R; Masur S; Baumann K; Schmidt B
    Bioorg Med Chem; 2011 Aug; 19(16):4903-9. PubMed ID: 21763147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of membrane lipid composition on the structure and activity of γ-secretase.
    Aguayo-Ortiz R; Straub JE; Dominguez L
    Phys Chem Chem Phys; 2018 Nov; 20(43):27294-27304. PubMed ID: 30357233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways.
    Duggan SP; McCarthy JV
    Cell Signal; 2016 Jan; 28(1):1-11. PubMed ID: 26498858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production.
    Wang J; Lu R; Yang J; Li H; He Z; Jing N; Wang X; Wang Y
    Nat Commun; 2015 Nov; 6():8876. PubMed ID: 26581893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
    Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
    Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MH84: A Novel γ-Secretase Modulator/PPARγ Agonist--Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer's Disease.
    Pohland M; Hagl S; Pellowska M; Wurglics M; Schubert-Zsilavecz M; Eckert GP
    Neurochem Res; 2016 Feb; 41(1-2):231-42. PubMed ID: 26721513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
    Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
    Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dependency of γ-secretase complex activity on the structural integrity of the bilayer.
    Zhou H; Zhou S; Walian PJ; Jap BK
    Biochem Biophys Res Commun; 2010 Nov; 402(2):291-6. PubMed ID: 20937251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. γ-Secretase Partitioning into Lipid Bilayers Remodels Membrane Microdomains after Direct Insertion.
    Barros M; Houlihan WJ; Paresi CJ; Brendel M; Rynearson KD; Lee CW; Prikhodko O; Cregger C; Chang G; Wagner SL; Gilchrist ML; Li YM
    Langmuir; 2020 Jun; 36(23):6569-6579. PubMed ID: 32432881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators.
    Bischoff FP; Velter AI; Minne G; Pieters S; Berthelot D; De Cleyn M; Gijsen HJM; Macdonald G; Surkyn M; Van Brandt S; Van Roosbroeck Y; Zavattaro C; Mercken M; Austin N; Dhuyvetter D; Borghys H; Ahmad I; Samanta SK
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1737-1745. PubMed ID: 31122869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breathing new life into the rational design of Alzheimer's therapeutics.
    Dries DR; Yu G
    Cell; 2021 Jan; 184(2):296-298. PubMed ID: 33482095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photo-controlled delivery of very long chain fatty acids to cell membranes and modulation of membrane protein function.
    Kong L; Dawkins E; Campbell F; Winkler E; Derks RJE; Giera M; Kamp F; Steiner H; Kros A
    Biochim Biophys Acta Biomembr; 2020 May; 1862(5):183200. PubMed ID: 31972163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β-Secretase.
    Nisha CM; Kumar A; Nair P; Gupta N; Silakari C; Tripathi T; Kumar A
    Adv Bioinformatics; 2016; 2016():9258578. PubMed ID: 27190510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.